Brief online writing intervention: Participants will be instructed to write for 20 minutes across 3 consecutive days. They will be writing based on the prompts given to them.
Control condition: Participants will be instructed to write in order to control for time and writing engagement.
Study summary
The purpose of this study is to develop and test two brief online writing interventions to improve parental acceptance of sexual and gender minority youth (SGMY) in the Southeast United States.
Eligibility
Sex
ALL
Min age
15 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. Parents are eligible if they meet the following criteria:
1. Be a parent, grandparent, or any other family member who considers themselves a guardian of an SGMY between 15-29 years old,
2. Live in the Southeast United States (Louisiana, Mississippi, Alabama, Georgia, South Carolina, North Carolina, Tennessee, Arkansas, Kentucky, Florida),
3. Identify as heterosexual and cisgender, and
4. Report non-acceptance of their SGMY.
2. SGMY are eligible if they meet the following criteria:
1. Self-identify as SGM,
2. Are 15-29 years old,
3. Live in the Southeast United States, and
4. Have a parent enrolled in the trial
Exclusion Criteria:
3. Any individual who meets any of the following criteria will be excluded from participation in this study:
1. Active mania, psychosis, or suicidality, and
2. Unable to provide informed consent.
Primary outcome measure(s)
Change in Parents' Rejecting and Supportive Behaviors Measured By the Parent Non-Acceptance Scale — Baseline, 5 Days Post-Baseline, and 3 Months Post-Baseline The 10-item Parent Non-Acceptance Scale is a self-reported instrument assessing positive and negative indicators of parental acceptance of their SGMY. Parents report level of agreement on a scale from 1 (Strongly Disagree) to 6 (Strongly Agree), with a higher score on negative indicators representing a higher level of non-acceptance and a higher score on positive indicators representing a lower level of non-acceptance.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
